ReviewClujul medical (1957)2017

Molecular targeted treatment of metastatic colorectal cancer: the cardiovascular adverse effects of Bevacizumab and Cetuximab.

Alexandra Gherman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.